Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant - PA: Epigenetics/epigenomics in human health or disease

Université Laval

$100,000.00

Delineation of the epigenomic principles underlying microglial transcriptional and cellular activity in chronic neurodegenerative diseases.

EF 2019-20

Résumé
Microglia are the immune cells residing in the brain and play key roles in its development maintenance of proper functioning, and immune response against infections and injuries. To date, most pathological conditions affecting the brain, ranging from neurodevelopment disorders like schizophrenia to neurodegenerative diseases like Alzheimer's, appear to involve an accompanying inflammatory response that is driven by microglia. However, the mechanisms involved in triggering this microglial-driven inflammatory response, or in sustaining it, are not well understood to this day. To large extent, the cellular functions of microglia stem from the genes that these cells express. Work by us and others recently demonstrated that discrete regions of the genome called enhancers are critical to ensure that genes are correctly expressed in microglia. However, how enhancers, in the number of 40,000 in microglia, are regulated in the brain under both under healthy and pathological conditions remains largely unknown. To investigate how these genomic regions contribute to gene regulation, we will characterize the interactions between proteins involved in gene regulation and enhancers. To do so, we will isolate microglia from the mouse brain and perform assays with next-generation sequencing technologies to reveal how enhancers are involved in specifying microglia gene expression in a given context. Collectively, this research program will enable a much greater understanding of the signaling and epigenetic mechanisms that are responsible for gene regulation microglia, and by extension, the mechanisms that underlie the cellular functions of microglia. Thus, precisely defining the epigenetic mechanisms that regulate microglia gene expression in mice as proposed by this research program represents a critical step towards the development of more efficient therapies to treat neuropsychiatric disorders and neurodegenerative diseases.
Programme
Project Grant - PA: Epigenetics/epigenomics in human health or disease
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
414921
Name
Gosselin David
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Genetics
Projecttitle
Delineation of the epigenomic principles underlying microglial transcriptional and cellular activity in chronic neurodegenerative diseases.
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Epigenetics/epigenomics in human health or disease
Keyworddelim
Atac-Seq; Chip-Seq; Distal Genomic Regulatory Elements; Epigenomics; Interferon Regulatory Factors; Microglia; Mouse; Neurodegenerative Diseases; Rna-Seq; Transcription
Abstract
Microglia are the immune cells residing in the brain and play key roles in its development maintenance of proper functioning, and immune response against infections and injuries. To date, most pathological conditions affecting the brain, ranging from neurodevelopment disorders like schizophrenia to neurodegenerative diseases like Alzheimer's, appear to involve an accompanying inflammatory response that is driven by microglia. However, the mechanisms involved in triggering this microglial-driven inflammatory response, or in sustaining it, are not well understood to this day. To large extent, the cellular functions of microglia stem from the genes that these cells express. Work by us and others recently demonstrated that discrete regions of the genome called enhancers are critical to ensure that genes are correctly expressed in microglia. However, how enhancers, in the number of 40,000 in microglia, are regulated in the brain under both under healthy and pathological conditions remains largely unknown. To investigate how these genomic regions contribute to gene regulation, we will characterize the interactions between proteins involved in gene regulation and enhancers. To do so, we will isolate microglia from the mouse brain and perform assays with next-generation sequencing technologies to reveal how enhancers are involved in specifying microglia gene expression in a given context. Collectively, this research program will enable a much greater understanding of the signaling and epigenetic mechanisms that are responsible for gene regulation microglia, and by extension, the mechanisms that underlie the cellular functions of microglia. Thus, precisely defining the epigenetic mechanisms that regulate microglia gene expression in mice as proposed by this research program represents a critical step towards the development of more efficient therapies to treat neuropsychiatric disorders and neurodegenerative diseases.
Competitiondate
201909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gosselin, David
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~